Kezar Life Sciences Ownership | Who Owns Kezar Life Sciences?
Kezar Life Sciences Ownership Summary
Kezar Life Sciences is owned by 0.01% institutional investors, 12.00% insiders, and 88.00% retail investors. Blackrock is the largest institutional shareholder, holding 1.14% of KZR shares. International Biotechnology Ord is the top mutual fund, with 4.80% of its assets in Kezar Life Sciences shares.
KZR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Kezar Life Sciences | 0.01% | 12.00% | 88.00% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 830.37K | 1.14% | $498.22K |
Northern trust | 449.78K | 0.62% | $269.87K |
D. e. shaw | 246.84K | 0.34% | $148.10K |
Bank of america corp /de/ | 105.39K | 0.14% | $63.23K |
Price t rowe associates inc /md/ | 83.60K | 0.11% | $51.00K |
Mackenzie financial | 58.71K | 0.08% | $35.23K |
Virtu financial | 35.66K | 0.05% | $21.00K |
Rhumbline advisers | 27.55K | 0.04% | $16.53K |
Morgan stanley | 7.13K | 0.01% | $4.28K |
Russell investments group | 6.43K | 0.01% | $3.86K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Virtu financial | 35.66K | 0.00% | $21.00K |
D. e. shaw | 246.84K | 0.00% | $148.10K |
Mackenzie financial | 58.71K | 0.00% | $35.23K |
Proshare advisors | - | - | - |
Jacobs levy equity management | - | - | - |
Fidelis capital partners | - | - | - |
Legal & general group | - | - | - |
Prelude capital management | - | - | - |
Renaissance | - | - | - |
Suvretta capital management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bank of america corp /de/ | 105.39K | - | 72.14K |
Mackenzie financial | 58.71K | 0.00% | 58.71K |
Price t rowe associates inc /md/ | 83.60K | - | 35.93K |
Virtu financial | 35.66K | 0.00% | 13.17K |
Russell investments group | 6.43K | - | 6.43K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Suvretta capital management | - | - | -7.17M |
Avidity partners management lp | - | - | -5.03M |
Blackrock | 830.37K | - | -3.79M |
Tang capital management | - | - | -3.64M |
Vanguard group | - | - | -2.74M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Mackenzie financial | 58.71K | 0.00% | 58.71K | $35.23K |
Russell investments group | 6.43K | - | 6.43K | $3.86K |
Macquarie group | 3.63K | - | 3.63K | $2.18K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -13.00 |
Nisa investment advisors | -50.00 |
Ubs group | -398.00 |
Citigroup | -518.00 |
Cibc private wealth group | -1.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 1 | -98.28% | 3,686 | -99.99% | - | 0.02% | - | -100.00% | 1 | -95.45% |
Sep 30, 2024 | 58 | -25.64% | 37,658,818 | -4.33% | 5 | 0.18% | 18 | -52.63% | 22 | -4.35% |
Jun 30, 2024 | 78 | -9.30% | 39,364,790 | -12.05% | 54 | 1.42% | 38 | - | 23 | -17.86% |
Mar 31, 2024 | 86 | 2.38% | 44,760,196 | -9.36% | 61 | 1.34% | 38 | -5.00% | 28 | 7.69% |
Dec 31, 2023 | 84 | -5.62% | 49,383,993 | -10.99% | 67 | 1.16% | 40 | 2.56% | 26 | -18.75% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
International Biotechnology Ord | 350.39K | 4.80% | - |
Biotech Growth Ord | 192.70K | 2.64% | - |
Vanguard Total Stock Mkt Idx Inv | 188.96K | 2.59% | 1.20K |
Vanguard Institutional Extnd Mkt Idx Tr | 76.47K | 1.05% | - |
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc | 693.06K | 0.95% | -100.25K |
Vifag 2002 SICAV | 45.00K | 0.62% | - |
Vanguard Balanced Index Inv | 37.87K | 0.52% | - |
Fidelity Extended Market Index | 34.57K | 0.47% | -220.00 |
NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 33.98K | 0.47% | 104.00 |
Fidelity Nasdaq Composite Index | 32.48K | 0.45% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 02, 2024 | Schiller Mark C. | Chief Legal Officer | Sell | $3.88K |
Feb 06, 2023 | Morningside Venture Investments Ltd | - | Sell | $275.32K |
Feb 03, 2023 | Morningside Venture Investments Ltd | - | Sell | $178.65K |
Feb 02, 2023 | Morningside Venture Investments Ltd | - | Sell | $359.50K |
Feb 01, 2023 | Morningside Venture Investments Ltd | - | Sell | $278.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q3 | - | 1 |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
KZR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools